Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease
M. Tibiletti (Manchester, United Kingdom), J. Naish (Manchester, United Kingdom), M. Heaton (Manchester, United Kingdom), J. Waterton (Manchester, United Kingdom), P. Hughes (Sheffield, United Kingdom), J. Eaden (Sheffield, United Kingdom), S. Skeoch (Bath, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), I. Bruce (Manchester, United Kingdom), S. Bianchi (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), G. Parker (Manchester, United Kingdom)
Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Session: Quantitative imaging in diffuse lung disease
Session type: Oral Presentation
Number: 4330
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Tibiletti (Manchester, United Kingdom), J. Naish (Manchester, United Kingdom), M. Heaton (Manchester, United Kingdom), J. Waterton (Manchester, United Kingdom), P. Hughes (Sheffield, United Kingdom), J. Eaden (Sheffield, United Kingdom), S. Skeoch (Bath, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), I. Bruce (Manchester, United Kingdom), S. Bianchi (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), G. Parker (Manchester, United Kingdom). Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease. 4330
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: